Personalized Psychiatry Market Intelligence Report Covers Trends, Segments And Regional Growth

The field of personalized psychiatry is gaining strong momentum as advancements in technology and a deeper understanding of individual mental health needs come together. This evolving sector promises more precise and tailored treatments for psychiatric conditions, supported by cutting-edge innovations and expanding digital healthcare options. Let's explore the current market size, key players, driving factors, emerging trends, and segmentation of this promising industry.

Forecasted Expansion in the Personalized Psychiatry Market Size by 2030
The personalized psychiatry market is set for rapid growth, projected to reach $12.73 billion by 2030 with a compound annual growth rate (CAGR) of 14.3%. This surge is largely driven by the rising demand for outcome-focused psychiatric care, broader adoption of AI and genomics in mental health contexts, and the growth of home-based and digital treatment options. Additionally, the focus on tailoring medication effectiveness and increased investment in precision psychiatry platforms contribute significantly to this upward trajectory. Key trends expected to shape the sector include wider use of pharmacogenomic-guided treatment plans, expansion of AI-based clinical decision support tools, growth in telepsychiatry models, integration of wearable tech and neuroimaging data, and heightened attention to early and accurate diagnoses.

The personalized psychiatry market size has grown rapidly in recent years. It will grow from $6.51 billion in 2025 to $7.46 billion in 2026 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to increasing awareness of mental health disorders, expansion of genetic testing in clinical psychiatry, rising adoption of telepsychiatry services, growing availability of mental health data platforms, increasing research funding for psychiatric precision medicine.

Download a free sample of the personalized psychiatry market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Factors Encouraging Growth in the Personalized Psychiatry Market
A growing emphasis on personalized drug efficacy is a central factor pushing the personalized psychiatry market forward. Tailoring psychiatric treatments to individual genetic profiles and environmental factors helps improve outcomes and reduce side effects, attracting interest from both patients and healthcare providers.
Moreover, the expansion of digital mental health services and home-based care solutions is enhancing accessibility, enabling patients to receive tailored psychiatric interventions conveniently. This shift supports greater market penetration and user acceptance of personalized psychiatry.

Leading Companies Influencing the Personalized Psychiatry Market
Several major players currently dominate the personalized psychiatry landscape, including Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb, Takeda Pharmaceutical Company, Boehringer Ingelheim, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Neurocrine Biosciences, Spring Health, Neumora Therapeutics Inc., Atai Life Sciences, Valera Health, Compass Pathways, Genomind, Woebot Health, Meru Health, Alto Neuroscience, Arcara Personalized Psychiatry, Mind Sync Therapeutics, Starling Minds, HMNC Holding GmbH, Pear Therapeutics, and Akili Interactive.
In a notable recent development, April Health Inc. merged with Wysa Ltd. in March 2025. This strategic move aims to combine Wysa's AI-powered mental health support with April Health's virtual behavioral health services, broadening personalized care accessibility through primary care providers. Wysa Ltd., known for leveraging artificial intelligence to offer evidence-based, individualized psychiatric assistance, is a key player in the digital mental health space.

View the full personalized psychiatry market report:
https://www.thebusinessresearchcompany.com/report/personalized-psychiatry-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Shaping the Future of Personalized Psychiatry
Technological innovation is at the forefront of future developments, with many companies focusing on personalized telepsychiatry services. These services provide remote, tailored psychiatric evaluation and treatment that consider each patient's genetic makeup, lifestyle, and environment via digital communication platforms.
For example, in April 2025, Alice's Psychiatry & Wellness, a US-based provider, launched a clinic offering compassionate, personalized psychiatric care across multiple states through both in-person and telepsychiatry models. This clinic integrates pharmacogenetic testing to customize medication plans according to patients' genetic profiles. By utilizing virtual platforms and ensuring continuous care from dedicated providers, the clinic exemplifies accessible, consistent, and inclusive mental health support aligned with personalized psychiatry principles.

Detailed Market Segmentation of Personalized Psychiatry
The personalized psychiatry market is segmented into several key categories for a comprehensive understanding:
1) By Type: Products, Services, Software
2) By Technology: Genetic Testing, Artificial Intelligence, Neurostimulation Technology, Digital Therapeutics
3) By Application: Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia, Attention-Deficit Hyperactivity Disorder (ADHD)
4) By End User: Clinics, Hospitals, Research Institutes, Homecare Settings

Further subsegments include:
- Products such as pharmacogenomic test kits, wearable devices, and brain imaging equipment
- Services encompassing telepsychiatry, personalized treatment planning, and behavioral assessments
- Software comprising clinical decision support tools, mental health applications, and virtual therapy platforms

This detailed segmentation highlights the diverse technologies and applications driving the personalized psychiatry market's growth and evolution.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.